H

HITS Tech Stack

AI platform for automated drug discovery and molecular optimization

IT Services and IT Consulting 서울특별시 11–50 employees Privately Held

HITS operates a physics-informed AI platform for pharma drug discovery, built on Python, Go, FastAPI, PostgreSQL, and Kubernetes on AWS. The tech stack and active projects reveal a company transitioning from public to private cloud while scaling ML infrastructure (Kubeflow, Airflow) to handle closed-loop lab automation and omics analysis—moving beyond virtual screening toward end-to-end experimental orchestration. Hiring velocity is accelerating with mid-level engineers and researchers, matching the complexity of their product commercialization and hyperlab service roadmap.

Tech Stack 25 technologies

Core StackPython Go FastAPI PostgreSQL Redis Kubernetes Helm ArgoCD React Next.js Cursor AWS Kubeflow Apache Airflow Zapier Mixpanel AWS EKS Argo Workflows R Claude NotebookLM ChatGPT Google Analytics 4 Google Tag Manager LinkedIn

What HITS Is Building

◆Challenges

High cost low efficiency drug development
High availability and scalability
Slow drug discovery process
Transition from public to private cloud
Long time to develop new drugs

▲Active Projects

Hyperlab service enhancement
Backend automation software
Customer support system
Omics analysis ai agent
Closed-loop experimental orchestration pipeline
Product commercialization of ai agent
Public to private cloud transition project
Ai automation pipeline with kubeflow and airflow
Hyper screening x
Chemical reaction prediction & lab automation

Hiring Activity

Accelerating6 roles · 6 in 30d

Department

Engineering

2

Research

2

Marketing

1

Seniority

Mid

3

Manager

1

Senior

1

Company intelligence

Find more companies like HITS by tech stack, pain points and active projects

Get started free

About HITS

HITS is a South Korea-based AI biotech company that automates molecular discovery for pharma and research institutions. The platform combines physics-based modeling with deep learning for hit discovery, hit-to-lead, and lead optimization phases. HITS partners with academic centers, CROs, contract research organizations, and pharmaceutical companies including research divisions at major conglomerates and regional biotech firms. The product surface includes virtual screening, chemical reaction prediction, lab automation integration, and an omics analysis agent—all orchestrated through a cloud-native backend. Core pain points center on accelerating timelines and reducing costs in early-stage drug development, where traditional approaches are slow and capital-intensive.

Headquarters서울특별시

Company Size11–50 employees

Hiring MarketsSouth Korea

Frequently Asked Questions

What tech stack does HITS use?

Python, Go, FastAPI, PostgreSQL, Redis, Kubernetes (AWS EKS), Helm, ArgoCD, Argo Workflows, Kubeflow, Apache Airflow, React, Next.js, R, and Claude for AI modeling.

What is HITS working on?

Active projects include closed-loop experimental orchestration, omics analysis AI agent, chemical reaction prediction and lab automation, hyperlab service enhancement, and a public-to-private cloud migration.